Evidence map›Paper›PMID 36838975›Full record

ArticleMolecules (Basel, Switzerland)2023

Design, Synthesis, and Pharmacology of New Triazole-Containing Quinolinones as CNS Active Agents.

Wennan Zhao, Mingxia Song, Yi Hua, Yangnv Zhu, Wenli Liu, Qishan Xia, Xianqing Deng, Yushan Huang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Wennan ZhaoHealth Science Center, Jinggangshan University, Ji'an 343009, China.
Mingxia SongHealth Science Center, Jinggangshan University, Ji'an 343009, China.
Yi HuaHealth Science Center, Jinggangshan University, Ji'an 343009, China.
Yangnv ZhuHealth Science Center, Jinggangshan University, Ji'an 343009, China.
Wenli LiuHealth Science Center, Jinggangshan University, Ji'an 343009, China.
Qishan XiaHealth Science Center, Jinggangshan University, Ji'an 343009, China.
Xianqing DengHealth Science Center, Jinggangshan University, Ji'an 343009, China.
Yushan HuangCenter for Evidence Based Medical and Clinical Research, First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, China.
Jinggangshan University · CNFirst Affiliated Hospital of Gannan Medical University · CN

Funding

National Natural Science Foundation of China 21562028National Natural Science Foundation of China 22167017
6 · The paper itself

Abstract

Epilepsy and major depressive disorder are the two of the most common central nervous system (CNS) diseases. Clinicians and patients call for new antidepressants, antiseizure medicines, and in particular drugs for depression and epilepsy comorbidities. In this work, a dozen new triazole-quinolinones were designed, synthesized, and investigated as CNS active agents. All compounds reduced the immobility time significantly during the forced swim test (FST) in mice at the dosage of 50 mg/kg. Compounds

Indexed as

Major Depressive DisorderQuinolonesAnimalsAntidepressive AgentsDepressionFluoxetineHindlimb SuspensionMiceMolecular Docking SimulationSwimmingTriazolesAntidepressive AgentsFluoxetineQuinolonesTriazolesanticonvulsantantidepressantantiseizureforced swim testGABAmaximal electroshock seizurequinolinonetriazole

Identifiers

PMID36838975
PMCPMC9965477
OpenAlexW4321377468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.